| FAK | Name: | N~6~-(trifluoroacetyl)-L-lysine | Formula: | C8 H13 F3 N2 O3 | SMILES: | O=C(O)C(N)CCCCNC(=O)C(F)(F)F | InChi: | InChI=1S/C8H13F3N2O3/c9-8(10,11)7(16)13-4-2-1-3-5(12)6(14)15/h5H,1-4,12H2,(H,13,16)(H,14,15)/t5-/m0/s1 | Definition date: | 2013-06-13 | Last modified: | 2024-09-27 | Release date: | 2014-02-19 | Identifier: | N~6~-(trifluoroacetyl)-L-lysine |
|
| FAO | Name: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S)-5-[(4aS,10aR)-7,8-dimethyl-2,4-dioxo-1,3,4,4a,5,10a-hexahydrobenzo[g]pteridin-10(2H)-yl]-2,3,4-trihydroxypentyl dihydrogen diphosphate | Formula: | C27 H37 N9 O15 P2 | SMILES: | O=C2NC(=O)NC3N(c1cc(c(cc1NC23)C)C)CC(O)C(O)C(O)COP(=O)(O)OP(=O)(O)OCC6OC(n5cnc4c(ncnc45)N)C(O)C6O | InChi: | InChI=1S/C27H37N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,18-21,24,26,32,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H2,33,34,42,43)/t14-,15+,16+,18-,19-,20+,21+,24+,26+/m0/s1 | Definition date: | 2006-12-13 | Last modified: | 2024-09-27 | Identifier: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S)-5-[(4aS,10aR)-7,8-dimethyl-2,4-dioxo-1,3,4,4a,5,10a-hexahydrobenzo[g]pteridin-10(2H)-yl]-2,3,4-trihydroxypentyl dihydrogen diphosphate (non-preferred name) |
|
| FAR | Name: | FARNESYL | Formula: | C15 H26 | SMILES: | C(=C/C)(CC/C=C(/CC/C=C(C)C)C)C | InChi: | InChI=1S/C15H26/c1-6-14(4)10-8-12-15(5)11-7-9-13(2)3/h6,9,12H,7-8,10-11H2,1-5H3/b14-6+,15-12+ | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (6E,10E)-2,6,10-trimethyldodeca-2,6,10-triene |
|
| FAW | Name: | (2S)-3-hydroxypropane-1,2-diyl ditetradecanoate | Formula: | C31 H60 O5 | SMILES: | O=C(OCC(CO)OC(=O)CCCCCCCCCCCCC)CCCCCCCCCCCCC | InChi: | InChI=1S/C31H60O5/c1-3-5-7-9-11-13-15-17-19-21-23-25-30(33)35-28-29(27-32)36-31(34)26-24-22-20-18-16-14-12-10-8-6-4-2/h29,32H,3-28H2,1-2H3/t29-/m0/s1 | Definition date: | 2015-04-14 | Last modified: | 2024-09-27 | Release date: | 2018-01-03 | Identifier: | (2S)-3-hydroxypropane-1,2-diyl ditetradecanoate |
|
| 1VL | Name: | (3S)-1-{[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]methyl}-3-hydroxy-1,3-dihydro-2H-indol-2-one | Formula: | C21 H23 N3 O4 | SMILES: | O=C2N(c1ccccc1C2O)CN3CCN(CC3)Cc4ccc5OCOc5c4 | InChi: | InChI=1S/C21H23N3O4/c25-20-16-3-1-2-4-17(16)24(21(20)26)13-23-9-7-22(8-10-23)12-15-5-6-18-19(11-15)28-14-27-18/h1-6,11,20,25H,7-10,12-14H2/t20-/m0/s1 | Definition date: | 2013-06-20 | Last modified: | 2024-09-27 | Release date: | 2014-04-16 | Identifier: | (3S)-1-{[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]methyl}-3-hydroxy-1,3-dihydro-2H-indol-2-one |
|
| FBE | Name: | (3E)-5-aminopent-3-enoic acid | Formula: | C5 H9 N O2 | SMILES: | O=C(O)C/C=C/CN | InChi: | InChI=1S/C5H9NO2/c6-4-2-1-3-5(7)8/h1-2H,3-4,6H2,(H,7,8)/b2-1+ | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (3E)-5-aminopent-3-enoic acid |
|
| 1VR | Name: | (3R)-3-amino-4-methylpentanoic acid | Formula: | C6 H13 N O2 | SMILES: | O=C(O)CC(N)C(C)C | InChi: | InChI=1S/C6H13NO2/c1-4(2)5(7)3-6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m1/s1 | Synonyms: | beta-3-homovaline | Definition date: | 2013-06-21 | Last modified: | 2024-09-27 | Release date: | 2013-09-04 | Identifier: | (3R)-3-amino-4-methylpentanoic acid |
|
| FBQ | Name: | 1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL | Formula: | C20 H18 F4 N2 O2 S | SMILES: | FC(F)(F)C(O)(O)c1cccc(c1)CSCc2c(c3c(F)cccc3nc2C)N | InChi: | InChI=1S/C20H18F4N2O2S/c1-11-14(18(25)17-15(21)6-3-7-16(17)26-11)10-29-9-12-4-2-5-13(8-12)19(27,28)20(22,23)24/h2-8,27-28H,9-10H2,1H3,(H2,25,26) | Synonyms: | 4-AMINO-5-FLUORO-2-METHYL-3-(3-TRIFLUOROACETYLBENZYLTHIOMETHYL)QUINOLINE | Definition date: | 2001-04-24 | Last modified: | 2024-09-27 | Identifier: | 1-[3-({[(4-amino-5-fluoro-2-methylquinolin-3-yl)methyl]sulfanyl}methyl)phenyl]-2,2,2-trifluoroethane-1,1-diol |
|
| 1W4 | Name: | S-(4-fluorophenyl) 3-(dimethylamino)-5-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)ethenyl]benzenecarbothioate | Formula: | C25 H24 F N O2 S | SMILES: | O=C(Sc1ccc(F)cc1)c3cc(C=Cc2cc(c(O)c(c2)C)C)cc(N(C)C)c3 | InChi: | InChI=1S/C25H24FNO2S/c1-16-11-18(12-17(2)24(16)28)5-6-19-13-20(15-22(14-19)27(3)4)25(29)30-23-9-7-21(26)8-10-23/h5-15,28H,1-4H3/b6-5+ | Definition date: | 2013-06-27 | Last modified: | 2024-09-27 | Release date: | 2013-10-02 | Identifier: | S-(4-fluorophenyl) 3-(dimethylamino)-5-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)ethenyl]benzenecarbothioate |
|
| FC0 | Name: | N-CARBOXY-L-PHENYLALANINE | Formula: | C10 H11 N O4 | SMILES: | O=C(O)C(NC(=O)O)Cc1ccccc1 | InChi: | InChI=1S/C10H11NO4/c12-9(13)8(11-10(14)15)6-7-4-2-1-3-5-7/h1-5,8,11H,6H2,(H,12,13)(H,14,15)/t8-/m0/s1 | Definition date: | 2010-05-11 | Last modified: | 2024-09-27 | Identifier: | N-carboxy-L-phenylalanine |
|
| 1WD | Name: | 3-sulfanylpyridine-2-carboxylic acid | Formula: | C6 H5 N O2 S | SMILES: | O=C(O)c1ncccc1S | InChi: | InChI=1S/C6H5NO2S/c8-6(9)5-4(10)2-1-3-7-5/h1-3,10H,(H,8,9) | Definition date: | 2013-07-03 | Last modified: | 2024-09-27 | Release date: | 2015-09-23 | Identifier: | 3-sulfanylpyridine-2-carboxylic acid |
|
| FCG | Name: | (N5,C4A)-(ALPHA-HYDROXY-PROPANO)-3,4,4A,5-TETRAHYDRO-FLAVIN-ADENINE DINUCLEOTIDE | Formula: | C30 H43 N9 O16 P2 | SMILES: | O=C2NC(O)C73N(c1cc(c(cc1N(C3N2)CC(O)C(O)C(O)COP(=O)(O)OP(=O)(O)OCC6OC(n5cnc4c(ncnc45)N)C(O)C6O)C)C)C(O)CC7 | InChi: | InChI=1S/C30H43N9O16P2/c1-12-5-14-15(6-13(12)2)39-19(42)3-4-30(39)27(35-29(47)36-28(30)46)37(14)7-16(40)21(43)17(41)8-52-56(48,49)55-57(50,51)53-9-18-22(44)23(45)26(54-18)38-11-34-20-24(31)32-10-33-25(20)38/h5-6,10-11,16-19,21-23,26-28,40-46H,3-4,7-9H2,1-2H3,(H,48,49)(H,50,51)(H2,31,32,33)(H2,35,36,47)/t16-,17+,18+,19+,21-,22+,23+,26+,27-,28+,30-/m0/s1 | Definition date: | 2006-01-05 | Last modified: | 2024-09-27 | Identifier: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S)-5-[(1R,3aS,4R,7aS)-1,4-dihydroxy-10,11-dimethyl-6-oxo-2,3,5,6,7,7a-hexahydro-1H-benzo[g]pyrrolo[2,1-e]pteridin-8(4H)-yl]-2,3,4-trihydroxypentyl dihydrogen diphosphate (non-preferred name) |
|
| FCL | Name: | 3-CHLORO-L-PHENYLALANINE | Formula: | C9 H10 Cl N O2 | SMILES: | Clc1cc(ccc1)CC(C(=O)O)N | InChi: | InChI=1S/C9H10ClNO2/c10-7-3-1-2-6(4-7)5-8(11)9(12)13/h1-4,8H,5,11H2,(H,12,13)/t8-/m0/s1 | Definition date: | 2003-07-31 | Last modified: | 2024-09-27 | Identifier: | 3-chloro-L-phenylalanine |
|
| 1WZ | Name: | 3-(dimethylamino)-5-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)ethenyl]benzoic acid | Formula: | C19 H21 N O3 | SMILES: | O=C(O)c1cc(cc(N(C)C)c1)C=Cc2cc(c(O)c(c2)C)C | InChi: | InChI=1S/C19H21NO3/c1-12-7-14(8-13(2)18(12)21)5-6-15-9-16(19(22)23)11-17(10-15)20(3)4/h5-11,21H,1-4H3,(H,22,23)/b6-5+ | Synonyms: | (E)-3-(dimethylamino)-5-(4-hydroxy-3,5-dimethylstyryl)benzoic acid | Definition date: | 2013-07-19 | Last modified: | 2024-09-27 | Release date: | 2013-10-02 | Identifier: | 3-(dimethylamino)-5-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)ethenyl]benzoic acid |
|
| 1X6 | Name: | O-[(2E)-3-AMINOPROP-2-ENOYL]-L-SERINE | Formula: | C6 H10 N2 O4 | SMILES: | O=C(OCC(C(=O)O)N)C=CN | InChi: | InChI=1S/C6H10N2O4/c7-2-1-5(9)12-3-4(8)6(10)11/h1-2,4H,3,7-8H2,(H,10,11)/b2-1+/t4-/m0/s1 | Definition date: | 2011-06-23 | Last modified: | 2024-09-27 | Identifier: | O-[(2E)-3-aminoprop-2-enoyl]-L-serine |
|
| 1XE | Name: | [5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)furan-2-yl]methyl (3R)-4-{[3-({(E)-2-[(2,2-dihydroxyethyl)sulfanyl]ethenyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl dihydrogen diphosphate | Formula: | C23 H34 N7 O18 P3 S | SMILES: | O=C(NC=CSCC(O)O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCc3oc(n2cnc1c(ncnc12)N)c(O)c3OP(=O)(O)O | InChi: | InChI=1S/C23H34N7O18P3S/c1-23(2,18(35)21(36)26-4-3-13(31)25-5-6-52-8-14(32)33)9-45-51(42,43)48-50(40,41)44-7-12-17(47-49(37,38)39)16(34)22(46-12)30-11-29-15-19(24)27-10-28-20(15)30/h5-6,10-11,14,18,32-35H,3-4,7-9H2,1-2H3,(H,25,31)(H,26,36)(H,40,41)(H,42,43)(H2,24,27,28)(H2,37,38,39)/b6-5+/t18-/m0/s1 | Definition date: | 2013-07-25 | Last modified: | 2024-09-27 | Release date: | 2013-07-31 | Identifier: | [5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)furan-2-yl]methyl (3R)-4-{[3-({(E)-2-[(2,2-dihydroxyethyl)sulfanyl]ethenyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl dihydrogen diphosphate |
|
| 1XG | Name: | (3R,7E,10E)-3-hydroxy-4-oxododeca-7,10-dienamide | Formula: | C12 H19 N O3 | SMILES: | O=C(CC/C=C/C/C=C/C)C(O)CC(=O)N | InChi: | InChI=1S/C12H19NO3/c1-2-3-4-5-6-7-8-10(14)11(15)9-12(13)16/h2-3,5-6,11,15H,4,7-9H2,1H3,(H2,13,16)/b3-2+,6-5+/t11-/m1/s1 | Definition date: | 2013-07-26 | Last modified: | 2024-09-27 | Release date: | 2014-04-02 | Identifier: | (3R,7E,10E)-3-hydroxy-4-oxododeca-7,10-dienamide |
|
| FDA | Name: | DIHYDROFLAVINE-ADENINE DINUCLEOTIDE | Formula: | C27 H35 N9 O15 P2 | SMILES: | O=C3C=2Nc1cc(c(cc1N(C=2NC(=O)N3)CC(O)C(O)C(O)COP(=O)(O)OP(=O)(O)OCC6OC(n5cnc4c(ncnc45)N)C(O)C6O)C)C | InChi: | InChI=1S/C27H35N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,32,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H2,33,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2H)-yl)-2,3,4-trihydroxypentyl dihydrogen diphosphate (non-preferred name) |
|
| FDL | Name: | N~6~-acetyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-lysinamide | Formula: | C18 H23 N3 O4 | SMILES: | O=C(NCCCCC(N)C(=O)Nc2ccc1c(OC(=O)C=C1C)c2)C | InChi: | InChI=1S/C18H23N3O4/c1-11-9-17(23)25-16-10-13(6-7-14(11)16)21-18(24)15(19)5-3-4-8-20-12(2)22/h6-7,9-10,15H,3-5,8,19H2,1-2H3,(H,20,22)(H,21,24)/t15-/m0/s1 | Definition date: | 2012-10-11 | Last modified: | 2024-09-27 | Release date: | 2012-11-30 | Identifier: | N~6~-acetyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-lysinamide |
|
| 1XY | Name: | (4R)-3,4-dihydro-2H-chromen-4-amine | Formula: | C9 H11 N O | SMILES: | O2c1ccccc1C(N)CC2 | InChi: | InChI=1S/C9H11NO/c10-8-5-6-11-9-4-2-1-3-7(8)9/h1-4,8H,5-6,10H2/t8-/m1/s1 | Definition date: | 2013-07-30 | Last modified: | 2024-09-27 | Release date: | 2013-08-07 | Identifier: | (4R)-3,4-dihydro-2H-chromen-4-amine |
|
| 1XZ | Name: | 3-(2~{H}-indazol-3-yl)-~{N}-[[1-[(1~{R},2~{R})-2-methoxycyclohexyl]-1,2,3-triazol-4-yl]methyl]-5-(propanoylamino)benzamide | Formula: | C27 H31 N7 O3 | SMILES: | CCC(=O)Nc1cc(cc(c1)c2[nH]nc3ccccc23)C(=O)NCc4cn(nn4)[CH]5CCCC[CH]5OC | InChi: | InChI=1S/C27H31N7O3/c1-3-25(35)29-19-13-17(26-21-8-4-5-9-22(21)31-32-26)12-18(14-19)27(36)28-15-20-16-34(33-30-20)23-10-6-7-11-24(23)37-2/h4-5,8-9,12-14,16,23-24H,3,6-7,10-11,15H2,1-2H3,(H,28,36)(H,29,35)(H,31,32)/t23-,24-/m1/s1 | Definition date: | 2021-06-15 | Last modified: | 2024-09-27 | Release date: | 2022-07-20 | Identifier: | 3-(2~{H}-indazol-3-yl)-~{N}-[[1-[(1~{R},2~{R})-2-methoxycyclohexyl]-1,2,3-triazol-4-yl]methyl]-5-(propanoylamino)benzamide |
|
| FDT | Name: | (7R)-6-FORMYL-7-(1-METHYL-1H-1,2,3-TRIAZOL-4-YL)-4,7-DIHYDRO-1,4-THIAZEPINE-3-CARBOXYLIC ACID | Formula: | C10 H10 N4 O3 S | SMILES: | O=C(O)C=1NC=C(C=O)C(SC=1)c2nnn(c2)C | InChi: | InChI=1S/C10H10N4O3S/c1-14-3-7(12-13-14)9-6(4-15)2-11-8(5-18-9)10(16)17/h2-5,9,11H,1H3,(H,16,17)/t9-/m0/s1 | Synonyms: | 7-(1-METHYL-1,2,3-TRIAZOL-4-YL)-6-FORMYL-2,7-DIHYDRO-[1,4]THIAZEPINE-3-CARBOXYLIC ACID | Definition date: | 2004-12-09 | Last modified: | 2024-09-27 | Identifier: | (7S)-6-formyl-7-(1-methyl-1H-1,2,3-triazol-4-yl)-4,7-dihydro-1,4-thiazepine-3-carboxylic acid |
|
| FDX | Name: | (2R,4S)-2-(1,3-dihydroxypropan-2-yl)-4-{[(3R,5R)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3,4-dihydro-2H-pyrrole-5-carboxylic acid | Formula: | C15 H25 N3 O6 S | SMILES: | CN(C)C(=O)C1CC(SC2CC(N=C2C(=O)O)C(CO)C(O)O)CN1 | InChi: | InChI=1S/C15H25N3O6S/c1-18(2)13(20)10-3-7(5-16-10)25-11-4-9(8(6-19)14(21)22)17-12(11)15(23)24/h7-11,14,16,19,21-22H,3-6H2,1-2H3,(H,23,24)/t7-,8-,9-,10-,11+/m1/s1 | Definition date: | 2021-12-15 | Last modified: | 2024-09-27 | Release date: | 2022-05-18 | Identifier: | (2R,4S)-4-{[(3R,5R)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-2-[(2S)-1,1,3-trihydroxypropan-2-yl]-3,4-dihydro-2H-pyrrole-5-carboxylic acid |
|
| 1Y6 | Name: | 4-fluorobenzoic acid | Formula: | C7 H5 F O2 | SMILES: | Fc1ccc(C(=O)O)cc1 | InChi: | InChI=1S/C7H5FO2/c8-6-3-1-5(2-4-6)7(9)10/h1-4H,(H,9,10) | Definition date: | 2013-07-31 | Last modified: | 2024-09-27 | Release date: | 2014-12-31 | Identifier: | 4-fluorobenzoic acid |
|
| FE0 | Name: | (1S,2S,3R,4R)-3-(hydroxymethyl)cyclopentane-1,2,4-triol | Formula: | C6 H12 O4 | SMILES: | OC[CH]1[CH](O)C[CH](O)[CH]1O | InChi: | InChI=1S/C6H12O4/c7-2-3-4(8)1-5(9)6(3)10/h3-10H,1-2H2/t3-,4-,5+,6+/m1/s1 | Definition date: | 2020-05-03 | Last modified: | 2024-09-27 | Release date: | 2021-01-27 | Identifier: | (1~{S},2~{S},3~{R},4~{R})-3-(hydroxymethyl)cyclopentane-1,2,4-triol |
|